Genfit SA is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. It develops diagnostic solution for cardiometabolic and neurodegenerative diseases. It focuses on a number of disorders, including diabetes, vascular inflammation, atherosclerosis and others. The Company works in collaboration with such pharmaceutical companies as Sanofi-Aventis, Solvay Group, Kowa Pharmaceutical, UCB Pharma, Pierre Fabre, Pfizer and Servier Laboratories. It operates wholly owned subsidiaries, such as Genfit Corporation, located in Cambridge, the United States and Genfit Pharmaceuticals SAS. As of December 31, 2010, Holding Biotech Avenir held a 24.15% stake in the Company�s shareholdings.